VANGUARD GROUP INC 13D/13G Filings for Myriad Genetics, Inc. (MYGN)

VANGUARD GROUP INC 13D and 13G filings for Myriad Genetics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-13
5:09 pm
Purchase		 2023-12-29 13G Myriad Genetics, Inc.
MYGN		 VANGUARD GROUP INC 9,954,233
11.120%		 642,472increase
(+6.90%)		 Filing
2023-02-09
11:27 am
Purchase		 2022-12-30 13G Myriad Genetics, Inc.
MYGN		 VANGUARD GROUP INC 9,311,761
11.490%		 162,240increase
(+1.77%)		 Filing
2022-02-10
08:27 am
Purchase		 2021-12-31 13G Myriad Genetics, Inc.
MYGN		 VANGUARD GROUP INC 9,149,521
11.460%		 852,657increase
(+10.28%)		 Filing
2021-02-10
11:28 am
Sale		 2020-12-31 13G Myriad Genetics, Inc.
MYGN		 VANGUARD GROUP INC 8,296,864
11.030%		 -23,710decrease
(-0.28%)		 Filing